CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00238212
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:23.617176+00:00
Published At: 2013-01-14T00:00:00+00:00
Record Updated At: 2013-01-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma of the Extrahepatic Bile Duct", "Adenocarcinoma of the Gallbladder", "Adenocarcinoma With Squamous Metaplasia of the Gallbladder", "Cholangiocarcinoma of the Extrahepatic Bile Duct", "Cholangiocarcinoma of the Gallbladder", "Recurrent Extrahepatic Bile Duct Cancer", "Recurrent Gallbladder Cancer", "Squamous Cell Carcinoma of the Gallbladder", "Unresectable Extrahepatic Bile Duct Cancer", "Unresectable Gallbladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-01-14"
protocolSection.identificationModule.nctId: "NCT00238212"
protocolSection.identificationModule.officialTitle: "Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.